An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases

Andrew Elagizi, Sergey Kachur, Carl J. Lavie, Salvatore Carbone, Ambarish Pandey, Francisco B. Ortega, Richard V. Milani

Research output: Contribution to journalReview article

54 Citations (Scopus)

Abstract

Obesity increases a number of cardiovascular disease (CVD) risk factors, but patients with many types of CVD may have a better prognosis if classified as overweight or obese, a phenomenon known as the “obesity paradox”. This paradoxical benefit of a medically unfavorable phenotype is particularly strong in the overweight and class I obesity, and less pronounced in the more severe or morbidly obese populations (class II–III and greater). Rather than an obesity paradox, it is possible that this phenomenon may represent a “lean paradox” in which individuals classified as normal weight or underweight may have a poorer prognosis with respect to CVD, as a result of a progressive catabolic state and lean mass loss. Cardiorespiratory fitness (CRF) is a fundamental part of this discussion. A greater CRF is associated with lower CVD risk, regardless of body mass index (BMI). Also, the assessment of body composition compartments (i.e., fat mass, fat-free mass, lean mass) and the presence of metabolic derangements may be better indicators of CVD risk than BMI alone. The focus of this review is to summarize the current evidence of the obesity paradox. Moreover, we discuss the utility and limitations of BMI for cardiometabolic risk stratification, in addition to concepts such as “metabolically healthy obesity” (MHO) and the “fat but fit” phenomenon, which describe patients who are diagnosed with obesity using BMI, but without major metabolic derangements and with greater CRF, respectively. Finally, we propose that obese patients presenting with an excess body fat, yet without metabolic abnormalities, should still be viewed as an “at risk” population, and as such should receive advice to change their lifestyle to improve their CRF and to prevent the development of impaired fasting glucose, diabetes mellitus and other CVD risk factors as a form of primary prevention.

Original languageEnglish (US)
Pages (from-to)142-150
Number of pages9
JournalProgress in Cardiovascular Diseases
Volume61
Issue number2
DOIs
StatePublished - Jul 1 2018

Fingerprint

Cardiovascular Diseases
Obesity
Body Mass Index
Fats
Thinness
Primary Prevention
Body Composition
Adipose Tissue
Life Style
Fasting
Diabetes Mellitus
Phenotype
Weights and Measures
Glucose
Cardiorespiratory Fitness
Population

Keywords

  • Atrial fibrillation
  • Cardiorespiratory fitness
  • Cardiovascular
  • Cardiovascular disease
  • Coronary heart disease
  • Heart failure
  • Obesity
  • Obesity paradox
  • Physical activity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. / Elagizi, Andrew; Kachur, Sergey; Lavie, Carl J.; Carbone, Salvatore; Pandey, Ambarish; Ortega, Francisco B.; Milani, Richard V.

In: Progress in Cardiovascular Diseases, Vol. 61, No. 2, 01.07.2018, p. 142-150.

Research output: Contribution to journalReview article

Elagizi, Andrew ; Kachur, Sergey ; Lavie, Carl J. ; Carbone, Salvatore ; Pandey, Ambarish ; Ortega, Francisco B. ; Milani, Richard V. / An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. In: Progress in Cardiovascular Diseases. 2018 ; Vol. 61, No. 2. pp. 142-150.
@article{225d31f3ba34435b876327be7e3f5cb2,
title = "An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases",
abstract = "Obesity increases a number of cardiovascular disease (CVD) risk factors, but patients with many types of CVD may have a better prognosis if classified as overweight or obese, a phenomenon known as the “obesity paradox”. This paradoxical benefit of a medically unfavorable phenotype is particularly strong in the overweight and class I obesity, and less pronounced in the more severe or morbidly obese populations (class II–III and greater). Rather than an obesity paradox, it is possible that this phenomenon may represent a “lean paradox” in which individuals classified as normal weight or underweight may have a poorer prognosis with respect to CVD, as a result of a progressive catabolic state and lean mass loss. Cardiorespiratory fitness (CRF) is a fundamental part of this discussion. A greater CRF is associated with lower CVD risk, regardless of body mass index (BMI). Also, the assessment of body composition compartments (i.e., fat mass, fat-free mass, lean mass) and the presence of metabolic derangements may be better indicators of CVD risk than BMI alone. The focus of this review is to summarize the current evidence of the obesity paradox. Moreover, we discuss the utility and limitations of BMI for cardiometabolic risk stratification, in addition to concepts such as “metabolically healthy obesity” (MHO) and the “fat but fit” phenomenon, which describe patients who are diagnosed with obesity using BMI, but without major metabolic derangements and with greater CRF, respectively. Finally, we propose that obese patients presenting with an excess body fat, yet without metabolic abnormalities, should still be viewed as an “at risk” population, and as such should receive advice to change their lifestyle to improve their CRF and to prevent the development of impaired fasting glucose, diabetes mellitus and other CVD risk factors as a form of primary prevention.",
keywords = "Atrial fibrillation, Cardiorespiratory fitness, Cardiovascular, Cardiovascular disease, Coronary heart disease, Heart failure, Obesity, Obesity paradox, Physical activity",
author = "Andrew Elagizi and Sergey Kachur and Lavie, {Carl J.} and Salvatore Carbone and Ambarish Pandey and Ortega, {Francisco B.} and Milani, {Richard V.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.pcad.2018.07.003",
language = "English (US)",
volume = "61",
pages = "142--150",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases

AU - Elagizi, Andrew

AU - Kachur, Sergey

AU - Lavie, Carl J.

AU - Carbone, Salvatore

AU - Pandey, Ambarish

AU - Ortega, Francisco B.

AU - Milani, Richard V.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Obesity increases a number of cardiovascular disease (CVD) risk factors, but patients with many types of CVD may have a better prognosis if classified as overweight or obese, a phenomenon known as the “obesity paradox”. This paradoxical benefit of a medically unfavorable phenotype is particularly strong in the overweight and class I obesity, and less pronounced in the more severe or morbidly obese populations (class II–III and greater). Rather than an obesity paradox, it is possible that this phenomenon may represent a “lean paradox” in which individuals classified as normal weight or underweight may have a poorer prognosis with respect to CVD, as a result of a progressive catabolic state and lean mass loss. Cardiorespiratory fitness (CRF) is a fundamental part of this discussion. A greater CRF is associated with lower CVD risk, regardless of body mass index (BMI). Also, the assessment of body composition compartments (i.e., fat mass, fat-free mass, lean mass) and the presence of metabolic derangements may be better indicators of CVD risk than BMI alone. The focus of this review is to summarize the current evidence of the obesity paradox. Moreover, we discuss the utility and limitations of BMI for cardiometabolic risk stratification, in addition to concepts such as “metabolically healthy obesity” (MHO) and the “fat but fit” phenomenon, which describe patients who are diagnosed with obesity using BMI, but without major metabolic derangements and with greater CRF, respectively. Finally, we propose that obese patients presenting with an excess body fat, yet without metabolic abnormalities, should still be viewed as an “at risk” population, and as such should receive advice to change their lifestyle to improve their CRF and to prevent the development of impaired fasting glucose, diabetes mellitus and other CVD risk factors as a form of primary prevention.

AB - Obesity increases a number of cardiovascular disease (CVD) risk factors, but patients with many types of CVD may have a better prognosis if classified as overweight or obese, a phenomenon known as the “obesity paradox”. This paradoxical benefit of a medically unfavorable phenotype is particularly strong in the overweight and class I obesity, and less pronounced in the more severe or morbidly obese populations (class II–III and greater). Rather than an obesity paradox, it is possible that this phenomenon may represent a “lean paradox” in which individuals classified as normal weight or underweight may have a poorer prognosis with respect to CVD, as a result of a progressive catabolic state and lean mass loss. Cardiorespiratory fitness (CRF) is a fundamental part of this discussion. A greater CRF is associated with lower CVD risk, regardless of body mass index (BMI). Also, the assessment of body composition compartments (i.e., fat mass, fat-free mass, lean mass) and the presence of metabolic derangements may be better indicators of CVD risk than BMI alone. The focus of this review is to summarize the current evidence of the obesity paradox. Moreover, we discuss the utility and limitations of BMI for cardiometabolic risk stratification, in addition to concepts such as “metabolically healthy obesity” (MHO) and the “fat but fit” phenomenon, which describe patients who are diagnosed with obesity using BMI, but without major metabolic derangements and with greater CRF, respectively. Finally, we propose that obese patients presenting with an excess body fat, yet without metabolic abnormalities, should still be viewed as an “at risk” population, and as such should receive advice to change their lifestyle to improve their CRF and to prevent the development of impaired fasting glucose, diabetes mellitus and other CVD risk factors as a form of primary prevention.

KW - Atrial fibrillation

KW - Cardiorespiratory fitness

KW - Cardiovascular

KW - Cardiovascular disease

KW - Coronary heart disease

KW - Heart failure

KW - Obesity

KW - Obesity paradox

KW - Physical activity

UR - http://www.scopus.com/inward/record.url?scp=85050987621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050987621&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2018.07.003

DO - 10.1016/j.pcad.2018.07.003

M3 - Review article

C2 - 29981771

AN - SCOPUS:85050987621

VL - 61

SP - 142

EP - 150

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 2

ER -